Stephen Farrand
Plus aucun poste en cours
Profil
Stephen Farrand formerly worked at Merck & Co., Inc., as Vice President-Bioprocess Development from 2009 to 2015, NantKwest, Inc., as Senior Vice President-Global Manufacturing from 2015 to 2016, Schering-Plough Research Institute, as VP-Global Biologics & Sterile Product Development, and Jounce Therapeutics, Inc., as Chief Technical Officer.
Dr. Farrand received his undergraduate degree from the University of Bath and doctorate degree from the University of Leicester.
Anciens postes connus de Stephen Farrand
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNITYBIO, INC. | Corporate Officer/Principal | 01/01/2016 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2015 |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
| JOUNCE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Stephen Farrand
| University of Bath | Undergraduate Degree |
| University of Leicester | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
